html5-img
1 / 40

Peripheral Vascular Disease in Cardiac Patients

Peripheral Vascular Disease in Cardiac Patients. Jason Finkelstein, M.D. Cardiology Fellow Tulane University HSC 9/23/03. P A D. Characterized by arterial stenosis and occlusions in the peripheral arterial bed Can be symptomatic or asymptomatic Under diagnosed and under treated disease

niveditha
Download Presentation

Peripheral Vascular Disease in Cardiac Patients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Peripheral Vascular Disease in Cardiac Patients Jason Finkelstein, M.D. Cardiology Fellow Tulane University HSC 9/23/03

  2. P A D Characterized by arterial stenosis and occlusions in the peripheral arterial bed • Can be symptomatic or asymptomatic • Under diagnosed and under treated disease • Patient and physician awareness is low

  3. P V D • Ranges in severity from intermittent claudication to limb ischemia • Patients have a decreased quality of life due to a reduction in walking distance and speed leading to immobility • Most cases of PAD are asymptomatic

  4. Prevalence • 27 million people in Europe and North America have PAD (16% of the population 55 yrs or older) • 10.5 million are symptomatic • 16.5 million are asymptomatic • Three recent programs have demonstrated high PAD detection rates when specific populations were at risk for PAD were screened

  5. POPADAD study • 8000 patients • 40 yrs or older with DM Type I or II • Had no clinical symptoms of arterial disease • Results: • 20.1% of patients had ABI < 0.9

  6. PAD Awareness & Detection • Total of 6979 patients • Ages 70 yrs or older or 50-69 with diabetes or smoking history • PAD was considered present if ABI< 0.9 or a h/x of limb revascularization • CVD was defined as coronary, cerebral, or aortic aneurysmal disease • Criqui, et al, JAMA 2001: 286; 1317-1324

  7. Results: • PAD was detected in 1865 pts ( 30%) • 44% of these pts had newly diagnosed PAD only • 366 pts had newly diagnosed PAD and CVD (35%) • Among pts with PVD, classic claudication was distinctly uncommon • PAD is relatively underdiagnosed by physicians • PAD patients were less intensely treated than patients with CVD • Criqui et al, JAMA 2001 286. 1317-1324

  8. Natural History of PAD • Associated with significant mortality because of association with coronary and cerebrovascular events including death, MI, and stroke • 6x more likely to die within 10 yrs than patients without PAD • 5 yr mortality rate in pts with claudication is about 30% • Continued use of smoking results in a two fold risk of mortality

  9. Prevalence • Severity of symptoms has been found to correlate with survival • San Diego Artery study • Survival rates decreased with increasing severity • Another study showed that patients with symptoms had a 22% survival rate over a 15 yr period compared to a 78% survival rate of pts w/o symptoms • Belch et al, Arch Intern Med; April 2003; 884-892

  10. Predictors of Mortality in PAD • 297 patients • 213 had intermittent claudication • 84 had CLI defined by gangrene, ulcerations or persistent rest pain > 2 weeks • All subjects had ABI < 0.9 • Results • Patients with CLI had a 1 yr death rate of 22% • 3 yr survival was 52% compared to 86% in pts with intermittent claudication • Data suggests that pts with advance PAD have widespread arteriosclerotic disease • CLI was a stronger predictor of death than a low ABI Pasaqualini et al, Amer Jour of Cardio 2001;Vol 88:1057-60

  11. Claudication • Patients suffer from peripheral atherosclerosis • Symptomatic deficiency in blood supply to exercising muscle which is relieved by rest • Largely a disorder of the elderly • Only 1-2% of those ages 37-69 • Clinical history extremely important

  12. Risk Factors • Diabetes mellitus • have worse arterial disease and poorer outcomes than non-diabetics • Advanced age • Hyperlipidemia • Cigarette smoking • Hypertension

  13. Cardiac Risk • Pts with PVD have a 60% risk of CAD • Up to 30 % of pts have correctable 3 vessel disease with reduced LVEF • Patients with an ABI < 0.9 are twice as likely to have CAD

  14. Clinical Presentation • Can vary from severe disabling discomfort at rest to a bothersome pain of seemingly little consequence • Can present with buttock, thigh, calf or foot claudication singly or in combination • Diminished pulses with occasional bruits over stenotic lesions • Poor wound healing, unilateral cool extremity, shiny skin, hair loss, and nail changes

  15. Claudication • Calf • Cramping in upper 2/3 usually due to SFA stenosis • Thigh • Usually occlusion of the common femoral artery • Foot • Occlusive disease of the tibial and peroneal vessels • Buttock and Hip • Aortoiliac occlusive disease (Lariche’s syndrome)

  16. Diagnostic tests • Ankle-brachial index • Measures the resting and post exercise systolic BP in both the ankle and arms • Normal > 1.0 • Below 0.9 has a 95 % sensitivity for detecting angiogram positive PVD • 0.4 to 0.9 suggests arterial obstruction • Highly predictive of morbidity and mortality of CV events linked to PAD • Below 0.4 represents advanced ischemia

  17. Diagnostic Tests • Segemental limb pressures • > 20 mmHg reduction significant • Duplex U/S • MRA • Conventional angiography

  18. Angiography • Indicated for: • Defining vessel anatomy • Evaluating therapy • Documenting disease

  19. Long term survival • 2, 296 patients reviewed from CASS found to have PAD • Mean follow up period was 10.4 yrs • Pts with PAD had a higher frequency of CV risk factors • HTN, DM, CHF, previous CABG, or smoked • Controlled for all independent risk factors • Vascular disease retained a highly significant correlation with mortality • Pts had a 25% increased risk of dying at any time during followup ( p< 0.001) Eagle et al, JACC 1994;23:1091-5

  20. Premature PAD • 59 male patients with premature PAD • Age of onset < 45 yrs of age • PAD assessed by ABI and CAD assessed by exercise treadmill testing or coronary angiogram • Mean ABI was 0.65 • Arteriography performed in 56/59 pts • Valentine et al, J of Vasc Surg (1994; 19; 668-674)

  21. Premature PAD • 30 month period of the study • 43 patients had significant CAD (73%) • 17 pts had single vessel disease • 4 pts had 2 vessel disease • 22 pts had 3 vessel disease • 32 pts experienced an MI and 23 pts requires an intervention to help control angina • 8% mortality rate in the study • Valentine et al, J Vasc Surg (1994; 19:668-674)

  22. Management of PAD & CAD • Close association of PAD and CAD • Pts with CAD undergoing PV surgery are at increased risk of early and late CV events • Coronary revasc. is likely to improve outcome but mortality rate after CABG is not as good as in pts w/o PVD • Recommends hemodynamic monitoring • Definitive guidelines are not available • Gersch et al, J am Coll Card; 1991;18:203-214

  23. PVD and Role of CRP • 51 pts with PVD who underwent lower limb revasc. (screened 170 pts) • 24 month f/u period • 39 pts had PTA and 12 pts had bypass surgery • CRP levels were measured pre-op All mortality, cardiac mortality and MI were considered major events • Rossi et al, Circulation 2002; 105:800-803

  24. PVD and Role of CRP • 34% incidence of fatal and nonfatal MI over 2 yrs • CRP > 9 predicted 60 % o f MI’s in pts undergoing lower limb revasc. ( p <0.04) • Conclusion • CRP level in pts with PVD severe enough for revasc. may give incremental information about CV events and had a high predictive value • Pts may benefit from therapy modulating the immune response • More studies needed • Rossi et al, Circulation; 2002; 105: 800-803

  25. PAD Management • Anti-platelet agents • Diabetic control • Smoking cessation • Anti-hypertensives • Statin therapy • Exercise rehabilitation • Revascularization/PTCA/stenting

  26. Revascularization • Indications for intervention (PTA) • Persistent limiting claudication that prevents patient from performing daily activities • Rest pain • Tissue loss • Patients who are poor surgical candidates • Long term success of PTA depends on site and length of the lesion • Limited to focal, short segment occlusions • No significant difference in outcome between PTA or surgery

  27. Revascularization • Lesions might be better treated surgically if: • Long segments • Multi focal stenoses • Long segment occlusions • Eccentric, calcified lesions

  28. Conclusion • Need to increase awareness of PAD and its consequences • Improve the identification of patients with symptomatic PAD • Initiate a screening protocol at high risk for PAD • Improve treatment rates for those who have been diagnosed • Increase the rates of early detection in asymptomatic patients

  29. Summary • PAD is a powerful indicator of systemic artherosclerosis • Mandates aggressive risk factor modification and pharmacologic therapy • Goal is to improve the functional capacity of our patients and decrease morbidity and mortality • Cardiologists need to take a more active role in treating PAD along with co-existing CAD

  30. Case #1 • Mr. EG is a 52 yr old male with PMHx of HTN, tobacco abuse and CAD with a 5 vessel CABG in June 2000 • LIMA – LAD • SVG to D1 • SVG to OM1 & OM2 • SVG to RCA

  31. Case #1 • Last cath was in April of 2001 which showed patent grafts and medical management was recommended • Now pt has recurrent chest pain on exertion < 1 block • Cardiolyte stress test revealed 1 mm ST depression and anterior ischemia. LVEF is 44%

  32. Case # 2 • Mr. JG is a 60 yr old male with PMHx of severe tobacco abuse, AAA, PVD with ischemic rest pain, Right CEA, HTN, who presents with occasional atypical angina • Persantine Cardiolyte stress test showed reversible anterior and septal ischemia

  33. Case # 2 • TEE revealed normal LVEF with mild inferobasal HK • Moderate to severe eccentric MR • Physical exam revealed b/l carotid bruits and 2/6 SEM

More Related